Error: Could not add to watchlist. X

Aberdeen Swiss Funds Global Pharma Equity Fund

+ Watchlist
SVBPHNI:SW
1,748.27
USD
1.57
0.09%
As of 00:59:30 ET on 07/02/2015.
Volume
0
Previous Close
1,749.84
52Wk Range
1,507.10 - 1,801.21
1 Yr Return
8.86%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
1,748.27
Total Assets (m USD) (on 07/02/2015)
129.704
Inception Date
09/30/1959
Last Dividend (on 11/18/2014)
5.06
Dividend Indicated Gross Yield
0.29%
Fund Managers
-
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
1.60%
Expense Ratio
1.66%
Top Fund Holdings
Name Position Value % of Fund
Novo Nordisk A/S 239.50 k 13.62 m 10.04
Novartis AG 127.30 k 13.13 m 9.68
Roche Holding AG 40.50 k 11.65 m 8.59
CVS Health Corp 107.60 k 10.68 m 7.88
Johnson & Johnson 105.50 k 10.47 m 7.72
Baxter International Inc 141.90 k 9.75 m 7.19
Astellas Pharma Inc 554.10 k 8.66 m 6.38
Teva Pharmaceutical Industries 139.90 k 8.45 m 6.23
L'Oreal SA 44.10 k 8.42 m 6.21
Sysmex Corp 116.30 k 6.45 m 4.76
Profile
Aberdeen Swiss Equity Fund Global Pharma is an open-end fund incorporated in Switzerland. The Fund invests worldwide in companies that are active in the pharmaceuticals, biotechnology and medical technology sectors. The Fund focuses on the United States and offers investors a transparent way to invest in the complex pharmaceuticals and biotechnology sectors.
ADDRESS
Credit Suisse Asset Management Funds
Sihlcity - Kalandergasse 4
CH-8070 Zurich
Switzerland
PHONE
41-44-335-11-11 Tel